Consistent with an intensified antitumor effect, immune profiling of Lewis lung cancer models demonstrated lower PD-L1 expression on tumor surfaces (Fig. 6d) and more tumor-infiltrating CD8+ T cells in mice receiving the combined THZ1 and antiPD-1 therapy (Fig. 6f). The gene discussed is CD274; the disease is lung carcinoma.